Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Obesity 3Breast Neoplasms 3Sexual Dysfunctions, Psychological 1Progesterone Resistance 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Arthralgia 1

Interventions

Progestins 2semaglutide 1Tirzepatide 1Resistance Training 1Nutrition Assessment 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Estrogen Replacement Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Hyperplasia × Letrozole × Other × Clear all
NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting
29 enrolled
GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡